- We are a multidisciplinary team that integrates the perspectives of disciplines from the molecular sciences to the social sciences to achieve a global vision and adopt a holistic approach to chronic pain, with highly qualified human resources and knowledge in pain neuroscience, genetics, fibromyalgia (FM) and neuroengineering.
- We are committed to innovation in the management of FM, and this requires complementary expertise and partnership to provide new responses to current health challenges.
- EpiGenBaP brings us the possibility of joining efforts, to define a common research protocol and to carry out an aggregated study in order to reach more solid conclusions. We are committed to innovation in FM management, and this requires complementary expertise and partnership to provide new answers to today’s health challenges.
- We are partners from 10 countries, which will allow us to integrate the geographical, socio-economic and cultural dimensions into the study of FM.
The consortium is composed by
- Three groups of international reference in the study central pain modulation, in FM as in other chronic pain diseases (led by Roland Staud, David Yarnitsky and Serge Marchand).
- Four groups (led by André Mouraux, André Dufour, Lars Arendt-Nielsen, and María T. Carrillo-de-la-Peña) have great expertise in the study of brain activity in chronic pain and FM
- Three groups are experts in the field of genetics (Angel Carracedo, USC), genetics and FM (Eva Kosek) and epigenetics (Lars Arendt-Nielsen)
- One group with large expertise in tDCS and rTMS (Sandra Carvalho)
- One group with large expertise on the clinical management of patients with FM and chronic pain (Elena Bignami)
- Two SMEs who are developing products for pain assessment, neuromodulation, and biomarker identification (Neurolectrics and QST.lab).
PhD, MD, he is founder and director of Center for Sensory-Motor Interaction, Aalborg University, Denmark, and founder and director of R&D at the clinical trial unit C4Pain. His research has been focused on translational pain, human bio-markers for the assessment of pain from skin, muscles and viscera in healthy test subjects and pain patients, and the development of human bio-markers for the screening of new pain-relieving drugs for humans. He is the current President of the International Association for the Study of Pain.
Neurologist, professor at the Faculty of Medicine and the Institute of Neuroscience (IONS) of UCLouvain (UCL). André Mouraux heads a multidisciplinary team of researchers working in the field of human pain (IONS), aiming to understand how the human brain processes nociceptive sensory information and how this leads to pain perception (read more).
Specialist in Rheumatology and researcher at the University of Florida (UF). Center of Excellence for Pain Research and Intervention (PRICE). His research interests focus on understanding the mechanisms of chronic pain and fatigue, specifically musculoskeletal disorders (including fibromyalgia, TMD, backpain, OA), using functional brain imaging and standard psychophysical and other sensory testing procedures to assess individual pain responding (read more).
Professor of cognitive neuroscience at the University of Strasbourg, and director of the Centre for Neurocognitive and Neurophysiological Research (CI2N). CI2N is a research and services platform under the supervision of the French National Centre for Scientific Research (CNRS) and the University of Strasbourg. His line of research focuses on the analysis of electroencephalographic activity to evaluate cognitive and sensory functions, including pain (read more).
PhD and professor at the Faculty of Psychology at the University of Minho, coordinator of the Neurotherapy and Experimental Psychopathology Group (NEP), and researcher at the Spaulding Rehabilitation Hospital, Department of Physical Medicine and Rehabilitation, Harvard Medical School (Boston). Her areas of interest are neuroscience, neuropsychology, clinical psychology, and neuromodulation.
Professor of Neurology at the Faculty of Medicine of Technion Israel Institute of Technology Head of the Dept of Neurology at Rambam Health Care Campus and head of the Clinical neurophysiology lab, where he has conducted research on pain mechanisms over last three decades. His main field of interest is pain modulation and clinical implications. Editor in Chief of PAIN Reports, IASP’s new open access Journal (read more).
Professor in the Department of Clinical Neurosciences at the Karolinska Institute. Specialist in rehabilitation medicine and pain relief, she leads a research group in the clinical field of pain. She is a pioneer in the area of conditioning pain modulation (CPM) in fibromyalgia, and how this relates to functional genetic polymorphisms (read more).
Professor at the Faculty of Medicine and Health Sciences at the University de Sherbrooke, and researcher at the University Hospital. His research focuses on the neurophysiological mechanisms responsible for the development and persistence of chronic pain. Vice President of Scientific Affairs at Génome Québec (read more).
Neuroelectrics is a digital brain health company specialized in the design and development of medical devices for EEG recording and transcranial stimulation, with headquarters in Barcelona and Boston. Ana Maiques, economist, is the founder and business executive of the company and was awarded by the Healthcare Innovation Prize at the World Innovation Summit in 2009, and by the European Commission’s Women Innovators Contest in 2014 (third prize).
QST.Lab is a spin-off company of the University of Strasbourg, created around the development of a new thermal stimulator for clinical research and diagnosis. It is supported by the CNRS. François Marival is the leader of QST.Lab. He is the director of the European Training Institute of business economics and has a solid background in business economics and management, including a Masters in Management and Business Administration (MBA, Strasbourg).